Related Experiment Video
Updated: Jul 24, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim
Claudia A Chiriboga1, Claudio Bruno2, Tina Duong3
1Department of Neurology, Columbia University Irving Medical Center, 180 Fort Washington Avenue # 552, New York, NY, 10032-3791, USA. cac3@cumc.columbia.edu.
No abstract available in PubMed .
More Related Videos
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
10:03Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Satellite Stem Cells and Muscular Dystrophy